Research programme: propofol buccal - Novaliq
Alternative Names: Propofol for buccal deliveryLatest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Novaliq
- Class Phenols; Small molecules
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Sedation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sedation in Germany (Buccal, Liquid)
- 22 Dec 2011 Propofol - Novaliq is available for licensing as of 22 Dec 2011. http://www.novaliq.de/ab_about.html
- 22 Dec 2011 Preclinical trials in Sedation in Germany (Buccal)